Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection (Q43632617)
Jump to navigation
Jump to search
scientific article published in May 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection |
scientific article published in May 2001 |
Statements
1 reference
Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection (English)
1 reference
Marchi S
1 reference
Costa F
1 reference
Bellini M
1 reference
Belcari C
1 reference
Mumolo MG
1 reference
Tornar A
1 reference
Spisni R
1 reference
Torelli E
1 reference
Maltinti G
1 reference
1 May 2001
1 reference
1 reference
13
1 reference
5
1 reference
547-550
1 reference
Identifiers
1 reference
1 reference